Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 11 Jul 2025
A new study conducted in Lake County, California—one of the most wildfire-affected regions in the country—has found that residents' anxiety and stress about climate change are associated with increased disaster-preparedness ...
Read Full NewsAripiprazole is associated with a lower risk for hyponatremia compared with olanzapine in patients treated with second-generation antipsychotics, a new cohort study shows.
Researchers evaluate changes in post-transplantation outcomes among patients with relapsed or refractory Hodgkin lymphoma from 2010 to 2022.
In a recent KFF survey, 43% of US adults said they had skipped their medication in the past year because of cost.
1.
Studies have shown that physical activity prevents cancer in patients who have been treated for cancer in the past.
2.
New policy review highlights the importance of health-related quality of life in advanced cancer
3.
In myelofibrosis, combinations of rufolitinib reduce spleen volume.
4.
Better treatments buoy multiple-myeloma patients, bound by research cuts and racial disparities
5.
More Data from Population-Based Studies Show CRC Screening Lowers Cancer Death Risk.
1.
The Benefits of Understanding Haptoglobin High: What You Need to Know
2.
Unlocking the Mystery of Granulomas: A Closer Look at the Causes and Treatment
3.
Unraveling the Complexities of Embryonal Carcinoma: A New Hope for Treatment
4.
Beyond the Brain Fog: The Complex Neurological Challenges and Therapeutic Advances
5.
Colorectal Cancer Uncovered: CME, Case Studies, and Clinical Strategies
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
An Intro to The Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- Advanced Breast Cancer Clinical Studies.
2.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
3.
Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Summarization of the New Perspective
5.
Blood Clotting Disorders Explained
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge